Search for: "Price v. Bayer Healthcare Pharmaceuticals, Inc." Results 1 - 20 of 29
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Sep 2011, 8:40 am by Peter Rost
Peter Rost is a former Pfizer Marketing Vice President providing services as a marketing expert witness on medical devices, pharmaceuticals and average wholesale prices. [read post]
30 May 2012, 1:37 pm by Peter Rost
Peter Rost is a former Pfizer Marketing Vice President providing services as a marketing expert witness on medical devices, pharmaceuticals and average wholesale prices. [read post]
15 Feb 2012, 7:42 am by Peter Rost
Peter Rost is a former Pfizer Marketing Vice President providing services as a marketing expert witness on medical devices, pharmaceuticals and average wholesale prices. [read post]
14 Sep 2011, 12:08 pm by Peter Rost
Peter Rost is a former Pfizer Marketing Vice President providing services as a marketing expert witness on medical devices, pharmaceuticals and average wholesale prices. [read post]
11 Feb 2011, 7:51 am by Peter Rost
"Ahead of these give-backs, they dramatically raise prices," Dr. [read post]
2 Oct 2010, 8:43 am by Peter Rost
"Ahead of these give-backs, they dramatically raise prices," Dr. [read post]
22 Jun 2011, 4:09 am by Marie Louise
Highlights this week included: US Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods:  Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) Baytril (Enrofloxacin) – US: In a rare move, District Court extends 30-month stay on FDA ANADA approval: Bayer Healthcare v Norbrook (FDA Law Blog) Europe seizure of generic drugs: Lilly settles with Indian generics (Generic… [read post]
14 Sep 2011, 12:07 pm by Peter Rost
Peter Rost is a former Pfizer Marketing Vice President providing services as a marketing expert witness on medical devices, pharmaceuticals and average wholesale prices. [read post]
16 Feb 2015, 1:44 am
  * Bayer feels the pain: branded Naproxen can't invoke the territoriality principleKatfriend Marty Schwimmer reports on Belmora LLC v Bayer Consumer Care AG and Bayer Healthcare LLC, 1:14-cv-00847-GBL (EDVA Feb. 6, 2015), a recent US District Court for the Eastern District of Virginia ruling that deals with Article 6bis of the Paris Convention in the US as it applies to Bayer’s trade mark ‘FLANAX’. [read post]
19 Sep 2013, 9:53 am by Bexis
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
22 Jun 2011, 7:09 am by Peter Rost
Peter Rost is a former Pfizer Marketing Vice President providing services as a marketing expert witness on medical devices, pharmaceuticals and average wholesale prices. [read post]
25 Dec 2012, 8:08 am by Shouvik Kumar Guha
Rajiv then came up with a penetrating analysis of an IPAB decision (Bayer v. [read post]
17 Feb 2012, 11:29 am by Bexis
Ortho-McNeil-Janssen Pharmaceuticals Inc., 2010 WL 3548474 (Pa. [read post]
9 Jan 2014, 1:37 pm
Md. 2012) (same); New York State Pesticide Coalition, Inc. v. [read post]
24 Sep 2009, 5:09 am
Plough, Inc., 863 P.2d 167, 177-78 (Cal. 1993); Patton v. [read post]
28 Sep 2009, 1:31 am
Plough, Inc., 863 P.2d 167, 177-78 (Cal. 1993); Patton v. [read post]